| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.5 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.5 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.037 | 0.5 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.018 | 0.5 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.5 |